RxDoctor Payments Data

Laura Donadio

Family · Lisbon, OHNPI 1942951215

Payments from drug & device makers

$626in general payments, 2019–2025

Across 35 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sage Therapeutics, LLC$108
  • AstraZeneca$101
  • Lilly USA, LLC$62
  • GSK$47
  • Pfizer$45
  • Sunovion Pharmaceuticals Inc.$35
  • plus $228 from 12 others

What the payments were for

  • Food & beverage$60597%
  • Other$213%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$626 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$278
Medicare patients
15
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter68$59,569
OzempicSemaglutide47$56,595
TrulicityDulaglutide38$40,839
JanuviaSitagliptin Phosphate43$33,397
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog21$31,113
JardianceEmpagliflozin28$24,510
FarxigaDapagliflozin Propanediol20$21,683
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$21,207
EliquisApixaban11$12,549
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$5,416
SymbicortBudesonide/Formoterol Fumarate15$3,852
Albuterol Sulfate HfaAlbuterol Sulfate147$3,636
Atorvastatin Calcium223$1,606
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,421
Omeprazole84$997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$47$59,56968 claims
Novo NordiskOzempic$18$56,59547 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$101$46,74264 claims
Lilly USA, LLCTrulicity$62$40,83938 claims
PfizerEliquis$45$12,54911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Lisbon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →